{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:03:41Z","timestamp":1794805421638,"version":"4.9.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The Autoimmune Encephalitis Registry in Latin American countries (REAL LABIC Project) is an initiative created to conduct research focused on the epidemiological and clinical aspects of autoimmune encephalitis (AE) in the region. This study describes the sociodemographic profile, clinical presentation, treatment, and follow-up outcomes of patients diagnosed with AE across multiple reference centers from Latin America.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective, multicenter cohort study was conducted in 10 hospitals across 6 countries from Latin America. Medical records of pediatric and adult patients hospitalized between July 2017 and June 2022 were reviewed. Inclusion criteria were diagnostic of probable or definite AE according to consensus diagnostic criteria by Graus et al. Comparative analyses were performed between pediatric and adult groups using hypothesis contrast tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 165 patients, 57.6% were under 18\u202fyears of age. Confirmed AE was more frequent in pediatric patients, with anti-NMDA receptor antibodies identified in 53.5% of cases (CSF\/serum). The median time from symptom onset to hospital admission was 8\u202fdays, significantly shorter in pediatrics (<jats:italic>p<\/jats:italic>\u202f=\u202f0.027). A preceding viral prodrome was more common also in pediatrics (<jats:italic>p<\/jats:italic>\u202f=\u202f0.003). ICU admission was required in 53.9% of cases, predominantly among pediatrics (<jats:italic>p<\/jats:italic>\u202f=\u202f0.011). First-line immunotherapy was administered in 92.1% of patients, most commonly combining corticosteroids and intravenous immunoglobulin. Early initiation of treatment (\u22647\u202fdays) was associated with better response in pediatrics. At six-month follow-up, 45.5% of patients showed persistent neurological disability (mRS: 2\u20135). Minor cognitive impairment was the most frequent long-term sequela. In-hospital complications were reported in 53.3% of cases, and the overall mortality rate was 19.4%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the first regional multicenter study of autoimmune encephalitis in Latin America highlighting the above findings. There were no significant differences in most of the analyzed variables between pediatric and adult populations. Future research should address the strengths and limitations of this registry with the aim of gaining a broader understanding of autoimmune encephalitis in our region.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1647087","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:12:09Z","timestamp":1756825929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Autoimmune encephalitis in Latin America. Clinical features and outcomes in pediatric and adult populations: retrospective cohort of The REAL LABIC Project"],"prefix":"10.3389","volume":"16","author":[{"given":"Miguel A.","family":"Vences","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoper A.","family":"Alarcon Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Marcela","family":"Araujo Chumacero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Canales-Pichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Saquisela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Dom\u00ednguez-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donoband","family":"Melgarejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00fal","family":"Reyes-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricela","family":"Garc\u00eda-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes Amnely","family":"Suarez Loro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibele","family":"Lopes Queiroz de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Domingo","family":"Barrientos Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Cristina","family":"Waetge Pires de Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bayona Pancorbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Gabriela","family":"Rom\u00e1n Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefany","family":"Espinoza-Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Granela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Flecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib Georges","family":"Moutran Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werther Brunow","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Pelcastre Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia Yuri Xavier","family":"Mizumoto Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz","family":"Sonta-Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Gramajo-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Edwin","family":"Ore Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Fabiola","family":"Garc\u00eda Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belkis","family":"de la Candelaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Agustin","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/brainsci12091130","article-title":"Autoimmune encephalitis: a physician\u2019s guide to the clinical spectrum diagnosis and management","volume":"12","author":"Patel","year":"2022","journal-title":"Brain Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti\u2013N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"606350","DOI":"10.3389\/fneur.2020.606350","article-title":"Autoimmune encephalitis in Latin America: a critical review","volume":"11","author":"Vasconcelos","year":"2021","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1934971","DOI":"10.1155\/ane\/1934971","article-title":"Challenges in access to diagnosis and treatment of autoimmune encephalitis in hospitals in Latin America and the Caribbean","volume":"2025","author":"Vences","year":"2025","journal-title":"Acta Neurol Scand"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.20453\/rnp.v88i2.5512","article-title":"Registro de Encefalitis Autoinmune en pa\u00edses de Latinoam\u00e9rica: proyecto REAL LABIC","volume":"88","author":"Vences","year":"2025","journal-title":"Rev Neuropsiquiatr"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s10072-021-05174-6","article-title":"Clinical characteristics, treatment and long-term prognosis in patients with anti-NMDAR encephalitis","volume":"42","author":"Raja","year":"2021","journal-title":"Neurol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1261638","DOI":"10.3389\/fnhum.2023.1261638","article-title":"Systematic review: clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis","volume":"17","author":"Zhao","year":"2023","journal-title":"Front Hum Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.47936\/encephalitis.2023.00171","article-title":"The association between autoimmune encephalitis mediated by N-methyl-D-aspartate receptor autoantibodies and COVID-19: a systematic review","volume":"4","author":"Sawalha","year":"2024","journal-title":"Encephalitis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4103\/neuroindia.NI_981_20","article-title":"Prevalence and factor associated with anti-N-methyl-D-aspartate receptor encephalitis among patients with medical conditions: a systematic review and meta-analysis","volume":"72","author":"Lee","year":"2024","journal-title":"Neurol India"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.braindev.2018.12.009","article-title":"Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: a multicenter retrospective\/prospective cohort study","volume":"41","author":"Pruetarat","year":"2019","journal-title":"Brain Dev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/ene.12911","article-title":"Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in Southwest China","volume":"23","author":"Wang","year":"2016","journal-title":"Eur J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e958","DOI":"10.1212\/NXI.0000000000000958","article-title":"Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in Western China","volume":"8","author":"Gong","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2016.12.019","article-title":"Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-D-aspartate receptor encephalitis: a systematic review of reported cases","volume":"68","author":"Zhang","year":"2017","journal-title":"Epilepsy Behav"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pediatrneurol.2022.05.004","article-title":"Autoimmune encephalitis in children","volume":"132","author":"Hardy","year":"2022","journal-title":"Pediatr Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0883073813500527","article-title":"Encefalitis l\u00edmbica asociada a anticuerpos anti-\u00e1cido glut\u00e1mico descarboxilasa en un ni\u00f1o: ampliando el espectro de enfermedades cerebrales inflamatorias pedi\u00e1tricas","volume":"29","author":"Mishra","year":"2014","journal-title":"J Child Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1441033","DOI":"10.3389\/fneur.2024.1441033","article-title":"Prognostic factors and treatment outcomes in pediatric autoimmune encephalitis: a multicenter study","volume":"15","author":"Abu Melha","year":"2024","journal-title":"Front Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7196\/SAMJ.2023.v113i3.780","article-title":"Autoimmune encephalitis: part 1 (epidemiology, pathophysiology and clinical spectrum)","volume":"113","author":"Hiesgen","year":"2023","journal-title":"S Afr Med J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1212\/CON.0000000000001464","article-title":"Pediatric autoimmune neurologic disorders","volume":"30","author":"Hacohen","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/jnnp-2018-318376","article-title":"Predictive value of electroencephalography in anti-NMDA receptor encephalitis","volume":"89","author":"Sonderen","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.clinph.2018.10.017","article-title":"EEG analysis in anti-NMDA receptor encephalitis: description of typical pat terns","volume":"130","author":"Jeannin-Mayer","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/CON.0000000000001448","article-title":"Autoimmune Encephalitis","volume":"30","author":"Irani","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","article-title":"Use and safety of immunotherapeutic management of N-methyl-D-aspartate receptor antibody encephalitis: a meta-analysis","volume":"78","author":"Nosadini","year":"2021","journal-title":"JAMA Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s13311-019-00725-4","article-title":"Eficacia del intercambio plasm\u00e1tico terap\u00e9utico en pacientes con encefalitis refractaria grave a f\u00e1rmacos anti-receptor NMDA","volume":"16","author":"Zhang","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref32","article-title":"Complicaciones intrahospitalarias en pacientes con encefalitis anti-NMDAR definida en un centro de tercer nive","volume-title":"Arch Neurocien","author":"Mart\u00ednez-Angeles","year":"2024"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"845365","DOI":"10.3389\/fimmu.2022.845365","article-title":"Risk factors for mortality in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3988\/jcn.2023.0242","article-title":"Outcome and sequelae of autoimmune encephalitis","volume":"20","author":"Kvam","year":"2024","journal-title":"J Clin Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.seizure.2021.09.007","article-title":"Predictors and prognoses of epilepsy after anti-neuronal antibody-positive autoimmune encephalitis","volume":"92","author":"Chen","year":"2021","journal-title":"Seizure"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"813174","DOI":"10.3389\/fimmu.2022.813174","article-title":"Acute symptomatic seizures and risk of epilepsy in autoimmune encephalitis: a retrospective cohort study","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1007\/s00415-024-12432-y","article-title":"Prognostic factors underlying the development of drug-resistant epilepsy in patients with autoimmune encephalitis: a retrospective cohort study","volume":"271","author":"Huang","year":"2024","journal-title":"J Neurol"},{"key":"ref38","first-page":"402","article-title":"Secuelas cognitivas en encefalitis inmunomediadas: cohorte de pacientes en Argentina","volume-title":"Medicina","author":"Palacios","year":"2023"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/dmcn.15101","article-title":"Neurological and cognitive outcomes after antibody-negative autoimmune encephalitis in children","volume":"64","author":"Gadian","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1213532","DOI":"10.3389\/fimmu.2023.1213532","article-title":"Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"106986","DOI":"10.1016\/j.clineuro.2021.106986","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: an observational and comparative study in Mexican children and adults","volume":"210","author":"Herrera-Mora","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.21149\/12803","article-title":"Stroke care and collaborative academic research in Latin America","volume":"64","author":"Mu\u00f1oz-Venturelli","year":"2022","journal-title":"Salud Publica Mex"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"631722","DOI":"10.3389\/fneur.2021.631722\/full","article-title":"The multi-partner consortium to expand dementia research in Latin America (ReDLat): driving multicentric research and implementation science","volume":"12","author":"Ibanez","year":"2021","journal-title":"Front Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.msard.2021.103038","article-title":"Research priorities in multiple sclerosis in Latin America: a multi-stakeholder call to action to improve patients care: research priorities in MS in LATAM","volume":"53","author":"Rojas","year":"2021","journal-title":"Mult Scler Relat Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1647087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:12:10Z","timestamp":1756825930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1647087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":45,"alternative-id":["10.3389\/fneur.2025.1647087"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1647087","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"1647087"}}